News | PreventCrypto.org
Clinical Infectious Diseases Advance Access published August 23, 2012
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with
ͳ
Ma
nu
sc
rip
t
CD4@
3UHYLRXVO\0H\Det alVKRZHGWKHYDOXHRI&5$*VFUHHQLQJLQDSURVSHFWLYHFRKRUW
XVLQJWKH&5$*ODWH[DJJOXWLQDWLRQDWDFRVWRILQ8JDQGD>@1RZZLWKDUHDOZRUOG
FRVWRIWKH&5$*/)$DWWKHFRVWSHUOLIHVDYHGZLWK&5$*VFUHHQLQJDQGSUHHPSWLYH
IOXFRQD]ROHWKHUDS\LV LQ8JDQGDDPRQJSHUVRQVZLWK&' FHOOVP/DQGSHU
Ac
TXDOLW\DGMXVWHGOLIH\HDUVDYHG 4$/< >@,QFRQWUDVWWRWKHFRVWRIFU\SWRFRFFDOPHQLQJLWLV
KRVSLWDOL]DWLRQ&5$*VFUHHQLQJDQGWDUJHWHGSUHHPSWLYHWUHDWPHQWRIWKRVH&5$*LVFRVW
VDYLQJWRKHDOWKFDUHV\VWHPVDW!&5$*SUHYDOHQFH )LJXUH
%XWLVWKLVSURJUDPRQO\UHOHYDQWWR$IULFD":KLOHHDUO\+,9WHVWLQJLVNH\WKH86
͵
Ma
nu
sc
rip
t
UHDOLW\LVWKDWRIQHZO\+,9GLDJQRVHG$PHULFDQVUHFHLYHGDQ$,'6GLDJQRVLVFRQFXUUHQWO\
RUZLWKLQ\HDURIWKHLU+,9GLDJQRVLVEHWZHHQ >@,Q1RUWK$PHULFDRXURSLQLRQLV
&5$*VFUHHQLQJVKRXOGDOVREHFRQVLGHUHGDPRQJWKRVHZKRGRSUHVHQWZLWKDGYDQFHG$,'6
DQG&' 7KH86FRVWRIFU\SWRFRFFDOPHQLQJLWLVKRVSLWDOL]DWLRQLVH[WUDRUGLQDULO\KLJKLQ
FRQWUDVWWR&5$*VFUHHQLQJ a IROORZHGE\SUHHPSWLYHWUHDWPHQWZLWKZHHNVRI
IOXFRQD]ROHSHU:+2JXLGHOLQHV DWPJGDLO\IRUZHHNVIROORZHGE\ZHHNVRI
PJGDLO\>@7KHDSSUR[LPDWHFRVWRIKRVSLWDOL]DWLRQIRUFU\SWRFRFFRVLVIURPRQH%RVWRQ
KRVSLWDOLQFOXGLQJURRPDQGERDUG GD\ OLSRVRPDODPSKRWHULFLQ aGD\ DQG
IOXF\WRVLQH aGD\ IRUGD\VLVRQDYHUDJH)RUWKLVFRVWDVVXPLQJWKDWWKH/)$
ZRXOGFRVWLQKLJKLQFRPHVHWWLQJVRQHFRXOGVFUHHQDSSUR[LPDWHO\SHUVRQVIRU
DV\PSWRPDWLFDQWLJHQHPLD
7KXVZKLOHWKHSUHYDOHQFHRIFU\SWRFRFFDODQWLJHQHPLDDPRQJWKRVHZLWK&'
FHOOVP/LVOLNHO\PXFKORZHULQ1RUWK$PHULFDWKDQLQ6XE6DKDUDQ$IULFDRU$VLDWKHFRVWRI
ce
pte
d
FU\SWRFRFFDOPHQLQJLWLVWUHDWPHQWLVDVWURQRPLFDOO\KLJKHU&5$*VFUHHQLQJLVOLNHO\FRVW
VDYLQJLQWKH86LIVFUHHQHGSRSXODWLRQSUHYDOHQFHZDV!7KXV86&5$*SUHYDOHQFH
GDWDDUHQHHGHG*LYHQWKHLPSURYHGFRVWFRQVLGHUDWLRQVWKH86'++62SSRUWXQLVWLF,QIHFWLRQ
JXLGHOLQHVVKRXOGUHH[DPLQHWKHEHQHILWRIURXWLQHSUH$57&5$*VFUHHQLQJIRUWKRVHZLWK
&' RUDPRQJSHUVRQVKRVSLWDOL]HGVKRUWO\DIWHU$57LQLWLDWLRQ>@:KLOHLGHDOO\LQWKH
IXWXUHWKLVSRSXODWLRQRIODWH+,9SUHVHQWHUVZLOOEHHOLPLQDWHGDPRQJWKRVHZKRGRSUHVHQWODWH
&5$*VFUHHQLQJLQWKH86PD\QRWRQO\EHFRVWVDYLQJEXWOLIHVDYLQJ
Ac
127(6
)XQGLQJ '%KDVUHFHLYHGLQVWLWXWLRQDOIXQGLQJWKURXJK1,+JUDQWV8$,
516.$,
&RQIOLFWVRILQWHUHVW 7KHDXWKRUKDYHQRSRWHQWLDOFRQIOLFWVRILQWHUHVW
Ͷ
5HIHUHQFHV
1.ȱ
ParkȱBJ,ȱWannwmuehlerȱKA,ȱMarstonȱBJ,ȱGovenderȱN,ȱPappasȱPG,ȱChillerȱTM.ȱ
Ma
nu
sc
rip
t
Estimationȱofȱtheȱcurrentȱglobalȱburdenȱofȱcryptococcalȱmeningitisȱamongȱ
personsȱlivingȱwithȱHIV/AIDS.ȱAIDSȱ2009;23:525Ȭ30.ȱ
2.ȱ
LiechtyȱCA,ȱSolbergȱP,ȱWereȱW,ȱetȱal.ȱAsymptomaticȱserumȱcryptococcalȱ
antigenemiaȱandȱearlyȱmortalityȱduringȱantiretroviralȱtherapyȱinȱruralȱUganda.ȱ
TropȱMedȱIntȱHealthȱ2007;12:929Ȭ35.ȱ
3.ȱ
MeyaȱDB,ȱManabeȱYC,ȱCastelnuovoȱB,ȱetȱal.ȱCostȬeffectivenessȱofȱserumȱ
cryptococcalȱantigenȱscreeningȱtoȱpreventȱdeathsȱamongȱHIVȬinfectedȱpersonsȱ
withȱaȱCD4+ȱcellȱcountȱ
Reconsidering Cryptococcal Antigen Screening in the U.S. among persons with
ͳ
Ma
nu
sc
rip
t
CD4@
3UHYLRXVO\0H\Det alVKRZHGWKHYDOXHRI&5$*VFUHHQLQJLQDSURVSHFWLYHFRKRUW
XVLQJWKH&5$*ODWH[DJJOXWLQDWLRQDWDFRVWRILQ8JDQGD>@1RZZLWKDUHDOZRUOG
FRVWRIWKH&5$*/)$DWWKHFRVWSHUOLIHVDYHGZLWK&5$*VFUHHQLQJDQGSUHHPSWLYH
IOXFRQD]ROHWKHUDS\LV LQ8JDQGDDPRQJSHUVRQVZLWK&' FHOOVP/DQGSHU
Ac
TXDOLW\DGMXVWHGOLIH\HDUVDYHG 4$/< >@,QFRQWUDVWWRWKHFRVWRIFU\SWRFRFFDOPHQLQJLWLV
KRVSLWDOL]DWLRQ&5$*VFUHHQLQJDQGWDUJHWHGSUHHPSWLYHWUHDWPHQWRIWKRVH&5$*LVFRVW
VDYLQJWRKHDOWKFDUHV\VWHPVDW!&5$*SUHYDOHQFH )LJXUH
%XWLVWKLVSURJUDPRQO\UHOHYDQWWR$IULFD":KLOHHDUO\+,9WHVWLQJLVNH\WKH86
͵
Ma
nu
sc
rip
t
UHDOLW\LVWKDWRIQHZO\+,9GLDJQRVHG$PHULFDQVUHFHLYHGDQ$,'6GLDJQRVLVFRQFXUUHQWO\
RUZLWKLQ\HDURIWKHLU+,9GLDJQRVLVEHWZHHQ >@,Q1RUWK$PHULFDRXURSLQLRQLV
&5$*VFUHHQLQJVKRXOGDOVREHFRQVLGHUHGDPRQJWKRVHZKRGRSUHVHQWZLWKDGYDQFHG$,'6
DQG&' 7KH86FRVWRIFU\SWRFRFFDOPHQLQJLWLVKRVSLWDOL]DWLRQLVH[WUDRUGLQDULO\KLJKLQ
FRQWUDVWWR&5$*VFUHHQLQJ a IROORZHGE\SUHHPSWLYHWUHDWPHQWZLWKZHHNVRI
IOXFRQD]ROHSHU:+2JXLGHOLQHV DWPJGDLO\IRUZHHNVIROORZHGE\ZHHNVRI
PJGDLO\>@7KHDSSUR[LPDWHFRVWRIKRVSLWDOL]DWLRQIRUFU\SWRFRFFRVLVIURPRQH%RVWRQ
KRVSLWDOLQFOXGLQJURRPDQGERDUG GD\ OLSRVRPDODPSKRWHULFLQ aGD\ DQG
IOXF\WRVLQH aGD\ IRUGD\VLVRQDYHUDJH)RUWKLVFRVWDVVXPLQJWKDWWKH/)$
ZRXOGFRVWLQKLJKLQFRPHVHWWLQJVRQHFRXOGVFUHHQDSSUR[LPDWHO\SHUVRQVIRU
DV\PSWRPDWLFDQWLJHQHPLD
7KXVZKLOHWKHSUHYDOHQFHRIFU\SWRFRFFDODQWLJHQHPLDDPRQJWKRVHZLWK&'
FHOOVP/LVOLNHO\PXFKORZHULQ1RUWK$PHULFDWKDQLQ6XE6DKDUDQ$IULFDRU$VLDWKHFRVWRI
ce
pte
d
FU\SWRFRFFDOPHQLQJLWLVWUHDWPHQWLVDVWURQRPLFDOO\KLJKHU&5$*VFUHHQLQJLVOLNHO\FRVW
VDYLQJLQWKH86LIVFUHHQHGSRSXODWLRQSUHYDOHQFHZDV!7KXV86&5$*SUHYDOHQFH
GDWDDUHQHHGHG*LYHQWKHLPSURYHGFRVWFRQVLGHUDWLRQVWKH86'++62SSRUWXQLVWLF,QIHFWLRQ
JXLGHOLQHVVKRXOGUHH[DPLQHWKHEHQHILWRIURXWLQHSUH$57&5$*VFUHHQLQJIRUWKRVHZLWK
&' RUDPRQJSHUVRQVKRVSLWDOL]HGVKRUWO\DIWHU$57LQLWLDWLRQ>@:KLOHLGHDOO\LQWKH
IXWXUHWKLVSRSXODWLRQRIODWH+,9SUHVHQWHUVZLOOEHHOLPLQDWHGDPRQJWKRVHZKRGRSUHVHQWODWH
&5$*VFUHHQLQJLQWKH86PD\QRWRQO\EHFRVWVDYLQJEXWOLIHVDYLQJ
Ac
127(6
)XQGLQJ '%KDVUHFHLYHGLQVWLWXWLRQDOIXQGLQJWKURXJK1,+JUDQWV8$,
516.$,
&RQIOLFWVRILQWHUHVW 7KHDXWKRUKDYHQRSRWHQWLDOFRQIOLFWVRILQWHUHVW
Ͷ
5HIHUHQFHV
1.ȱ
ParkȱBJ,ȱWannwmuehlerȱKA,ȱMarstonȱBJ,ȱGovenderȱN,ȱPappasȱPG,ȱChillerȱTM.ȱ
Ma
nu
sc
rip
t
Estimationȱofȱtheȱcurrentȱglobalȱburdenȱofȱcryptococcalȱmeningitisȱamongȱ
personsȱlivingȱwithȱHIV/AIDS.ȱAIDSȱ2009;23:525Ȭ30.ȱ
2.ȱ
LiechtyȱCA,ȱSolbergȱP,ȱWereȱW,ȱetȱal.ȱAsymptomaticȱserumȱcryptococcalȱ
antigenemiaȱandȱearlyȱmortalityȱduringȱantiretroviralȱtherapyȱinȱruralȱUganda.ȱ
TropȱMedȱIntȱHealthȱ2007;12:929Ȭ35.ȱ
3.ȱ
MeyaȱDB,ȱManabeȱYC,ȱCastelnuovoȱB,ȱetȱal.ȱCostȬeffectivenessȱofȱserumȱ
cryptococcalȱantigenȱscreeningȱtoȱpreventȱdeathsȱamongȱHIVȬinfectedȱpersonsȱ
withȱaȱCD4+ȱcellȱcountȱ